Cyclops
9 known investors
Find your way into Cyclops
Cyclops Medtech develops a portfolio of vestibular diagnostic and therapy products—including videonystagmography (VNG/VOG), video head impulse testing (vHIT), dynamic visual acuity, stabilometry platforms, VR-based vestibular rehabilitation, and a smart balance board—to diagnose and treat dizziness and balance disorders. Its tools serve clinicians across neurotology, neurology, physiotherapy, audiology, and ophthalmology.
Investors · 9
Capria VenturesBengaluru · $300K – $1M
Castle Island Venturesreported · 2 sourcesBoston · $100K – $5M
Circle & Co.reported · 2 sources$130K – $780K
Coinbase Venturesreported · 2 sourcesStamford · $100K – $10M
Nava Venturesreported · 2 sourcesSan Francisco
Also in the syndicate · 4
F-PrimeGlobal PayTech VenturesLasagna VenturesShift4 Payments
Funding
SEC filings, press & company announcements$20M disclosed across 1 of 2 rounds · 2026
- $20MSeries AJul 2026 · 5 sources
Nava Ventures (lead), Castle Island Ventures, Circle, Coinbase Ventures, F-Prime, Global PayTech Ventures, Lasagna Ventures, Shift4 Payments
Source ↗ - Undisclosed amountseed roundMar 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Cyclops do?
- Cyclops Medtech develops a portfolio of vestibular diagnostic and therapy products—including videonystagmography (VNG/VOG), video head impulse testing (vHIT), dynamic visual acuity, stabilometry platforms, VR-based vestibular rehabilitation, and a smart balance board—to diagnose and treat dizziness and balance disorders. Its tools serve clinicians across neurotology, neurology, physiotherapy, audiology, and ophthalmology.
- Who are Cyclops's investors?
- Cyclops's investors include Capria Ventures, Castle Island Ventures, Circle & Co., Coinbase Ventures, Nava Ventures.
- How much funding has Cyclops raised?
- Cyclops has disclosed $20M raised across 1 of its 2 known rounds.